Please use this identifier to cite or link to this item: https://cris.library.msu.ac.zw//handle/11408/5485
Full metadata record
DC FieldValueLanguage
dc.contributor.authorM Chipinduroen_US
dc.contributor.authorC Timireen_US
dc.contributor.authorJ Chirendaen_US
dc.contributor.authorR Matamboen_US
dc.contributor.authorE Munemoen_US
dc.contributor.authorB Makamureen_US
dc.contributor.authorA F Nhidzaen_US
dc.contributor.authorW Tinagoen_US
dc.contributor.authorV Chikwashaen_US
dc.contributor.authorM Ngwenyaen_US
dc.contributor.authorJ Mutsvangwaen_US
dc.contributor.authorJ Z Metcalfeen_US
dc.contributor.authorC Sandyen_US
dc.date.accessioned2023-03-29T06:38:54Z-
dc.date.available2023-03-29T06:38:54Z-
dc.date.issued2022-01-01-
dc.identifier.urihttps://cris.library.msu.ac.zw//handle/11408/5485-
dc.description.abstractBACKGROUND: We conducted the first national TB prevalence survey to provide accurate estimates of bacteriologically confirmed pulmonary TB disease among adults aged ≥15 years in 2014.METHODS: A TB symptoms screen and chest X-ray (CXR) were used to identify presumptive TB cases who submitted two sputum samples for smear microscopy, liquid and solid culture. Bacteriological confirmation included acid-fast bacilli smear positivity confirmed using Xpert® MTB/RIF and/or culture. Prevalence estimates were calculated using random effects logistic regression with multiple imputations and inverse probability weighting.RESULTS: Of 43,478 eligible participants, 33,736 (78%) were screened; of these 5,820 (17%) presumptive cases were identified. There were 107 (1.9%) bacteriologically confirmed TB cases, of which 23 (21%) were smear-positive. The adjusted prevalences of smear-positive and bacteriologically confirmed TB disease were respectively 82/100,000 population (95% CI 47-118/100,000) and 344/100,000 (95% CI 268-420/100,000), with an overall all-ages, all-forms TB prevalence of 275/100,000 population (95% CI 217-334/100,000). TB prevalence was higher in males, and age groups 35-44 and ≥65 years. CXR identified 93/107 (87%) cases vs. 39/107 (36%) using the symptom screen.CONCLUSION: Zimbabwe TB disease prevalence has decreased relative to prior estimates, possibly due to increased antiretroviral therapy coverage and successful national TB control strategies. Continued investments in TB diagnostics for improved case detection are required.en_US
dc.language.isoenen_US
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen_US
dc.relation.ispartofInternational Journal of Tuberculosis and Lung Disease (IJTLD)en_US
dc.subjectTB prevalenceen_US
dc.subjectTB diseaseen_US
dc.subjectTBen_US
dc.subjectZimbabween_US
dc.titleTB prevalence in Zimbabwe: a national cross-sectional survey, 2014en_US
dc.typeresearch articleen_US
dc.identifier.doi10.5588/ijtld.21.0341-
dc.contributor.affiliationDepartment of Pathology, Faculty of Medicine and Health Sciences (FMHS), Midlands State University, Gweru, Zimbabween_US
dc.contributor.affiliationInternational Union Against Tuberculosis and Lung Disease (The Union), Paris, France, National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.en_US
dc.contributor.affiliationDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe.en_US
dc.contributor.affiliationBiomedical Research and Training Institute, Harare, Zimbabwe.en_US
dc.contributor.affiliationNational Microbiology Reference Laboratory, Harare, Zimbabwe.en_US
dc.contributor.affiliationBiomedical Research and Training Institute, Harare, Zimbabwe.en_US
dc.contributor.affiliationBiomedical Research and Training Institute, Harare, Zimbabwe.en_US
dc.contributor.affiliationDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe, School of Medicine, University College Dublin, Dublin, Ireland.en_US
dc.contributor.affiliationDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe.en_US
dc.contributor.affiliationWorld Health Organisation, Harare Country Office, Zimbabwe.en_US
dc.contributor.affiliationBiomedical Research and Training Institute, Harare, Zimbabwe.en_US
dc.contributor.affiliationDivision of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, CA, USA.en_US
dc.contributor.affiliationNational TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.en_US
dc.relation.issn1815-7920en_US
dc.description.volume26en_US
dc.description.issue1en_US
dc.description.startpage57en_US
dc.description.endpage64en_US
item.cerifentitytypePublications-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.openairetyperesearch article-
Appears in Collections:Research Papers
Files in This Item:
File Description SizeFormat 
TB prevalence in Zimbabwe.pdfAbstract109.41 kBAdobe PDFView/Open
Show simple item record

Page view(s)

66
checked on Dec 1, 2024

Download(s)

20
checked on Dec 1, 2024

Google ScholarTM

Check

Altmetric


Items in MSUIR are protected by copyright, with all rights reserved, unless otherwise indicated.